Global resilience and new strategies needed for antimicrobial stewardship during the COVID-19 pandemic and beyond
- PMID: 35572210
- PMCID: PMC9087764
- DOI: 10.1002/jac5.1622
Global resilience and new strategies needed for antimicrobial stewardship during the COVID-19 pandemic and beyond
Abstract
Resilience is having the ability to respond to adversity proactively and resourcefully. The coronavirus disease 2019 (COVID-19) pandemic's profound impact on antimicrobial stewardship programs (ASP) requires clinicians to call on their own resilience to manage the demands of the pandemic and the disruption of ASP activities. This article provides examples of ASP resilience from pharmacists and physicians from seven countries with different resources and approaches to ASP-The United States, The United Kingdom, Canada, Nigeria, Lebanon, South Africa, and Colombia. The lessons learned pertain to providing ASP clinical services in the context of a global pandemic, developing new ASP paradigms in the face of COVID-19, leveraging technology to extend the reach of ASP, and conducting international collaborative ASP research remotely. This article serves as an example of how resilience and global collaboration is sustaining our ASPs by sharing new "how to" do antimicrobial stewardship practices during the COVID-19 pandemic.
Keywords: COVID‐19 pandemic; SARS‐CoV‐2; antimicrobial stewardship; pharmacists; physicians.
© 2022 The Authors. JACCP: Journal of the American College of Clinical Pharmacy published by Wiley Periodicals LLC on behalf of Pharmacotherapy Publications, Inc.
Conflict of interest statement
Debra A. Goff; Timothy P. Gauthier; Bradley J. Langford; Pavel Prusakov; Ubaka Chukwuemka M; Benedict C. Nwomeh; Khalid A. Yunis; Therese Saad; Maria Virginia Villegas; Diane Ashiru‐Oredope and Pablo J. Sanchez: see conflict of interest disclosure form submitted with manuscript. Andrew Morris, Philip Howard, Dena van den Bergh, and Nela Martinez have no relevant conflicts of interest.
Figures
References
-
- Weiner‐Lastinger LM, Pattabiraman V, Konnor RY, et al. The impact of coronavirus disease 2019 (COVID‐19) on healthcare‐associated infections in 2020: a summary of data reported to the National Healthcare Safety Network. Infect Control Hosp Epidemiol. 2021;118:1–14. - PubMed
-
- Etienne C. Americas Report Surge in Drug‐Resistant Infections due to Misuse of Antimicrobials During Pandemic; 2021. https://www.paho.org/en/news/17-11-2021-americas-report-surge-drug-resis...
LinkOut - more resources
Full Text Sources
Miscellaneous